|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/705 | |
| C07K 16/28 | |||
| G01N 33/50 | |||
| C07K 14/47 | |||
| C12N 5/0783 |
| (11) | Number of the document | 3392270 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18175738.6 |
| Date of filing the European patent application | 2012-09-11 | |
| (97) | Date of publication of the European application | 2018-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161535086 P | 2011-09-15 | US |
| (72) |
ROBBINS, Paul F., US
ROSENBERG, Steven A., US
ZHU, Shiqui, US
FELDMAN, Steven A., US
MORGAN, Richard A., US
|
| (73) |
The United States of America, as Represented by the Secretary Department of Health and Human Services,
National Institutes of Health Office of Technology Trensfer 6011 Executive Boulevard Suite 325 Msc 7660, Bethesda, MD 20852-7660,
US
|
| (54) | T CELL RECEPTORS RECOGNIZING HLA-A1- OR HLA-CW7-RESTRICTED MAGE |
| T CELL RECEPTORS RECOGNIZING HLA-A1- OR HLA-CW7-RESTRICTED MAGE |